Page 4 - Nxc 201 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nxc 201. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nxc 201 Today - Breaking & Trending Today

Immix Biopharma Subsidiary Nexcella Completes Pre-IND

LOS ANGELES, June 26, 2023 (GLOBE NEWSWIRE) Nexcella, Inc., a subsidiary of Immix Biopharma, Inc. (“Nexcella”, “Company”, “We” or “Us”), a. ....

Ilya Rachman , Gabriel Morris , Alex Lobo , Los Angeles , Immix Biopharma Inc , Nexcella Inc , International Myeloma Working Group , Exchange Commission , Immix Biopharma , Pre Investigational New Drug , Chief Executive Officer , Chief Financial Officer , Multiple Myeloma , Uniform Response Criteria , Tissue Specific Therapeutics , Orphan Drug Designation , Rare Pediatric Disease Designation , Risk Factor , Annual Report , Nasdaq Immx , Immix Biopharma , Nxc 201 ,